Axa
RNA

Axa’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Axa’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-275,001
Closed -$2.32M – 1556
2014
Q3 		$2.32M Buy
275,001
+26,306
+11% +$249K 0.01% 710
2014
Q2 		$3.14M Buy
+248,695
New +$2.02M 0.01% 668

Other funds holding RNA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PCM
Proxima Capital Management New York $21M AUM 3.49% 1-Year Est. Return

Axa's RNA Position: Q4 2014 in Review

Axa sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2014, closing a stake of 275,001 shares — an estimated $2.32M sold.

Axa first reported a position in RNA in Q2 2014 and held it in 2 quarters. The position peaked at $3.14M in Q2 2014. 47 funds tracked by Wall St. Rank hold RNA as of Q4 2014.

  • Axa reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2014 after selling out during the quarter.
  • Axa sold 275,001 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2014, an estimated $2.32M.
  • Axa first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q2 2014 and held it in 2 quarters.
  • Axa's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $3.14M in Q2 2014.
  • 47 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2014.

Based on Axa's 13F filing for Q4 2014, filed 13 Feb 2015.